Biosimilars for the Treatment of Psoriasis A Systematic Review of Clinical Trials and Observational Studies
JAMA Dermatology, 2023.
Duc Binh Phan; Sarah Elyoussfi; Michael Stevenson; Mark Lunt; Richard B. Warren; Zenas Z. N. Yiu
Read publication: JAMA Dermatology
Related
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study...
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoria...
Uptake of tumour necrosis factor - alpha inhibitor biosimilars for psoriasis: A drug utilisation stu...
0 Comments